Whoop gets full Medicare payment only if patients' blood pressure, A1C and LDL improve or stay controlled
Whoop, accepted into Medicare's ACCESS program, must show better or controlled blood pressure, A1C and LDL cholesterol to be paid in full. Chief medical officer Ami Bhatt told the STAT Summit that simplifying the app comes first for patients 65 and older.
The Scientist · Science desk

What happened
- ACCESS is a 10-year pilot, and its directory of initial participants, published last month, lists 55 companies.
- Each patient gets a wearable, a 12-month app subscription and access to clinicians who help them interpret their data.
- Whoop announced clinician data-sharing this year, shortly before the FDA closed a warning letter that had called its blood pressure-estimating feature a medical device.
Why it matters
- cost Whoop carries the risk. Bhatt described the aim as keeping the cost off the patient and placing the demand on the company.
- constraint Payment is tied to clinical measures, so heavy app use cannot by itself earn the full amount.
- exposure The five-millimeter blood pressure result is Bhatt's statement on stage, with no published study in STAT's account, and ACCESS will ask Whoop for results in Medicare patients.
Bhatt's case for older patients is about how easy it is to share data. Surveys suggest, she said, that even the oldest patients, the Silent Generation now past 80, trust the clinicians who treat them with their data [3]. "It's not that they're averse to giving data," she said. "It's how easy can we make it for that population to be able to share their data." [4] She put "simplification of the app" at number one on the roadmap [5]. Whoop is also working with the National Council on Aging and AARP on personalizing the product to older adults' individual priorities [6].
The payment design puts the first year on the company. "Whoop takes responsibility for, in 12 months, I am going to make these people better," Bhatt said [7]. Medicare pays the participating companies based on their health outcomes [9]. Bhatt said her role is to help a company that sold a product intentionally binned as wellness develop and demonstrate outcomes closer to clinical practice [13]. Whoop's recent $575 million raise drew investors including Mayo Clinic and Qatar's sovereign wealth fund [19].
Users check the app eight times a day on average, Bhatt said [14]. She also noted that research on continuous glucose monitors, the original wearable for diabetes, suggests engagement does not necessarily translate to better health outcomes [15]. Her answer is outcomes: Whoop has shown, she said, a decrease of five millimeters of mercury in blood pressure in individuals on Whoop [22].
The thing this doesn't tell you is who those individuals were, how many there were, or what they were compared with. STAT describes Whoop's customer base as mostly young and fit, and says the company has never been known for marketing to an older population [16]. If the five-millimeter result came from people like that, it is a weak forecast for Medicare patients 65 and up with high blood pressure, high cholesterol, obesity or prediabetes. We would want the age range, the denominator and a comparison group before leaning on it. STAT's account does not describe the underlying study, what the simplified app will change, or when it ships.
Bhatt also described the limits of continuous data from the exam room. "I had some really great patients who would print out binders of their wearable data," she said [17]. She said that despite her interest and the patient's engagement, the data was impossible to handle in a 20-minute visit [18].
What to watch
- Whether Whoop publishes the study behind the five-millimeter blood pressure result, with age range and comparison group.
- What the simplified app changes for users 65 and older, and when it ships.
- Outcome results from ACCESS patients at the end of their first 12-month subscription year.
Clarity's read
What the record supports and how the coverage leans. The claims behind it follow.
Reality
- Evidence40
- Adoption15
- Hype gap+20
- Incentives60
- Confidence55
Claim ledger
Ranked by verification strength, evidence, and original report placement.
- [1]
Whoop was accepted into Medicare's ACCESS program this year as one of the first consumer wearable companies, making it available at no cost to many traditional Medicare patients 65 and up.
- [2]
To receive full payment under the ACCESS model, Whoop must show it improved or controlled measures tied to its patients' chronic conditions, including blood pressure, hemoglobin A1C and LDL cholesterol.
- [3]
Surveys suggest, according to Bhatt, that even members of the Silent Generation, who are older than 80 today, trust their clinicians with their data.
- [4]
Bhatt said: "It's not that they're averse to giving data. It's how easy can we make it for that population to be able to share their data."
- [5]
Bhatt said simplification of the app is number one on Whoop's roadmap.
- [6]
Whoop is working with the National Council on Aging and AARP to think about how to personalize the product to older adults' individual priorities.
- [7]
Bhatt said: "Whoop takes responsibility for, in 12 months, I am going to make these people better."
- [8]
ACCESS is a 10-year pilot program that published a directory of initial participants last month, listing 55 companies.
- [9]
Medicare will pay the ACCESS companies based on their health outcomes.
- [10]
Whoop serves ACCESS patients with high blood pressure, high cholesterol, obesity and prediabetes.
- [11]
Whoop will provide ACCESS patients with a wearable, a 12-month subscription to its app, and access to clinicians who can help them make sense of their data and offer advice.
- [12]
Whoop announced this year the ability for users to discuss their wearable data with clinicians, shortly before the FDA closed its warning letter that had said Whoop's blood pressure-estimating feature qualified as a medical device rather than a wellness feature.
- [13]
Bhatt said it was her role to help Whoop, which until recently focused on selling a product intentionally binned in the wellness category, develop and demonstrate outcomes that bring it closer to clinical practice.
- [14]
Whoop users check the app eight times a day on average, according to Bhatt.
- [15]
Research into continuous glucose monitors, the original wearable for diabetes, suggests that engagement does not necessarily translate to better health outcomes, Bhatt said.
- [16]
Whoop has never been known for marketing to an older population; performance athletes headline its ads, and its customer base is mostly young and fit.
- [17]
Bhatt said: "I had some really great patients who would print out binders of their wearable data."
- [18]
Bhatt said that despite her interest and the patient's engagement, the binders of wearable data were impossible to handle in a 20-minute visit.
- [19]
Whoop recently raised $575 million from investors including Mayo Clinic and the sovereign wealth fund of Qatar.
- [20]
Ami Bhatt is Whoop's newly appointed chief medical officer and spoke at the STAT Summit in Boston on Wednesday; she previously chaired the FDA's digital health advisory committee.
- [21]
Bhatt said the goal is to bring technology closer to the patient without putting the cost on the patient, and instead to put the demand on the company.
- [22]
Bhatt said Whoop has shown a decrease in blood pressure of five millimeters of mercury in individuals on Whoop.
Get this ledger inside ChatGPT. Ask about any of our stories and the answer brings its figure, each claim’s verdict and the sources. Free, no account.
Sources
1 independent publisher whose own reporting we read for this story.
- statnews.comHow consumer tech company Whoop is building for Medicare patients
1 article · October 14, 2026
Topics and entities
Follow any of these and your For You feed starts watching them — no settings page required.